Synthesis and biological evaluation of phosphonate analogues of nevirapine. 2013

Jay Parrish, and Leah Tong, and Michael Wang, and Xiaowu Chen, and Eric B Lansdon, and Carina Cannizzaro, and Xubin Zheng, and Manoj C Desai, and Lianhong Xu
Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA. Jay.Parrish@gilead.com

A series of nevirapine-based analogues containing the phosphonate functionality were prepared and evaluated in vitro against HIV RT. The effect of the phosphonate was evaluated against the wild type and Y181C HIV replication. An in vivo PK study was performed on a select analogue.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019829 Nevirapine A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS. BI-RG-587,Nevirapine Hemihydrate,Viramune,BI RG 587,BIRG587,Hemihydrate, Nevirapine
D063065 Organophosphonates Carbon-containing phosphonic acid compounds. Included under this heading are compounds that have carbon bound to either OXYGEN atom or the PHOSPHOROUS atom of the (P Phosphonate,Phosphonates,Phosphonic Acid Esters,Acid Esters, Phosphonic,Esters, Phosphonic Acid

Related Publications

Jay Parrish, and Leah Tong, and Michael Wang, and Xiaowu Chen, and Eric B Lansdon, and Carina Cannizzaro, and Xubin Zheng, and Manoj C Desai, and Lianhong Xu
June 2000, Archives of pharmacal research,
Jay Parrish, and Leah Tong, and Michael Wang, and Xiaowu Chen, and Eric B Lansdon, and Carina Cannizzaro, and Xubin Zheng, and Manoj C Desai, and Lianhong Xu
January 2001, European journal of medicinal chemistry,
Jay Parrish, and Leah Tong, and Michael Wang, and Xiaowu Chen, and Eric B Lansdon, and Carina Cannizzaro, and Xubin Zheng, and Manoj C Desai, and Lianhong Xu
September 2011, Carbohydrate research,
Jay Parrish, and Leah Tong, and Michael Wang, and Xiaowu Chen, and Eric B Lansdon, and Carina Cannizzaro, and Xubin Zheng, and Manoj C Desai, and Lianhong Xu
February 2004, Bioorganic & medicinal chemistry letters,
Jay Parrish, and Leah Tong, and Michael Wang, and Xiaowu Chen, and Eric B Lansdon, and Carina Cannizzaro, and Xubin Zheng, and Manoj C Desai, and Lianhong Xu
April 2013, Bioorganic & medicinal chemistry,
Jay Parrish, and Leah Tong, and Michael Wang, and Xiaowu Chen, and Eric B Lansdon, and Carina Cannizzaro, and Xubin Zheng, and Manoj C Desai, and Lianhong Xu
August 2003, Bioorganic & medicinal chemistry letters,
Jay Parrish, and Leah Tong, and Michael Wang, and Xiaowu Chen, and Eric B Lansdon, and Carina Cannizzaro, and Xubin Zheng, and Manoj C Desai, and Lianhong Xu
September 2003, Organic letters,
Jay Parrish, and Leah Tong, and Michael Wang, and Xiaowu Chen, and Eric B Lansdon, and Carina Cannizzaro, and Xubin Zheng, and Manoj C Desai, and Lianhong Xu
July 2006, Organic letters,
Jay Parrish, and Leah Tong, and Michael Wang, and Xiaowu Chen, and Eric B Lansdon, and Carina Cannizzaro, and Xubin Zheng, and Manoj C Desai, and Lianhong Xu
August 2003, Chemical communications (Cambridge, England),
Jay Parrish, and Leah Tong, and Michael Wang, and Xiaowu Chen, and Eric B Lansdon, and Carina Cannizzaro, and Xubin Zheng, and Manoj C Desai, and Lianhong Xu
November 2013, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!